Diagnostics

Health Investor awards

Check4Cancer wins Diagnostics Provider of the Year at the 2018 Health Investor Awards

Fri, 15/06/2018 - 08:30
London, UK, 15th June 2018 / Sciad Newswire / Check4Cancer is delighted to announce it has been awarded ‘Diagnostics p

Domainex appoints Chris Brown as Chief Financial Officer

Wed, 06/12/2017 - 08:00
Cambridge, UK, 6th December 2017 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is p

Professor Trevor Jones interviews industry leaders at Pharma Integrates 2017

Thu, 26/10/2017 - 07:30
London, UK, 26th October 2017 / Sciad Newswire / This year’s Pharma Integrates conference in London, 15th-16th Nove

NPL re-launches to accelerate access to new health innovations

Tue, 26/09/2017 - 00:15
New approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise

Minomic clinical study progresses for MILGa in prostate, bladder, and pancreatic cancer

Thu, 29/06/2017 - 07:30
Australian immuno-oncology company Minomic International Ltd is proceeding to the second stage of its pioneering MILGa clinical trial of MiltuximabTM, a chimeric version of Minomic’s MIL-38 anti-Glypican1 antibody conjugated to the radioactive isotope 67Gallium.
ProAxsis

ProAxsis Gains CE Mark for Active Neutrophil Elastase Immunoassay

Fri, 30/09/2016 - 10:12
ProAxsis Limited is pleased to announce that it has successfully registered a CE Mark for its novel ProteaseTag® Active Neutrophil Elastase Immunoassay.

NALIA Systems Files New Patent Applications to Expand Product Range

Mon, 12/09/2016 - 11:15
London, UK, 12th September 2016 / Sciad Newswire / NALIA Systems is pleased to announce the filing of two new patent applications that highlight the co

BÜHLMANN Laboratories Opens North American Affiliate

Wed, 20/01/2016 - 13:00
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire.

Pages